Aditya Birla Sun Life ELSS Tax Saver Fund
An Open ended Equity Linked Saving Scheme with a statutory lock-in of 3 years and tax benefit
July 2026
| Equity Scheme |  |
 |
 |
 |
An Open ended Equity Linked Saving Scheme with a statutory lock-in of 3 years and tax benefit
July 2026
| Equity Scheme | |
|
|
|
| Investment Objective | |
| An open-ended equity linked savings scheme (ELSS) with the objective of long term growth of capital through a portfolio with a target Investment Objective allocation of 80% equity, 20% debt and money market securities. The Scheme does not guarantee/ indicate any returns. There is no assurance that the objective of the Scheme will be achieved. | |
| Fund Category: ELSS | |
 |
|
| Fund Snapshot | |
| Date of Allotment : Mar 29, 1996 | |
| Benchmark:Nifty 500 TRI | |
| Fund Manager - Mr. Dhaval Shah Managing the Fund Since: November 01, 2024 Experience in Managing the Fund: 1.7 Years |
|
| SIP: Monthly: Minimum ₹ 500/- and in multiples of ₹ 500/- thereafter |
|
| Application Amount for fresh subscription: ₹ 500 (plus in multiplies of ₹ 1) |
|
| Minimum Additional Investment: ₹ 500 (plus in multiplies of ₹ 1) |
|
| Load Structure (as % of NAV) (Incl. for SIP) | |
| Entry Load: | NIL |
| Exit Load: | NIL |
| Count of Securities: 63 | |
| AUM as on July 31, 2026 (in ₹Crore) | |
| Month End AUM | 14,659.85 |
| Monthly Average AUM | 14,615.15 |
| Base Expense Ratio (BER) | |
| Regular | 1.45% |
| Direct | 0.83% |
| BER excludes brokerage incurred towards execution of trades, transaction cost & statutory levies as applicable to investors. | |
| NAV as on July 31, 2026 | |
| Regular Growth | 62.25 |
| Regular IDCW$ | 190.98 |
| Direct Growth | 69.99 |
| Direct IDCW$ | 439.89 |
| $Income Distribution cum capital withdrawal | |
| Valuation Parameters | |
| Average P/E | 30.07 |
| Average P/BV | 5.18 |
| Average Dividend Yield | 0.99 |
| Top 10 Sectoral Contribution (in %) |
 |
| Market Capitalisation |
 |
| Volatility Measures | |
| Portfolio Turnover | 0.24 |
| Standard Deviation | 14.43% |
| Sharpe Ratio | 0.45 |
| Beta | 0.93 |
| Treynor Ratio | 0.07 |
Note: Standard Deviation, Sharpe Ratio & Beta are calculated on Annualised basis using 3 years history of monthly returns. Risk FreeRate assumed tobe 5.41%(FBIL OvernightMIBOR as on 31 July, 2026) for calculating SharpeRatio
| Rating Profile of Portfolio |  |
| Sector/Issuer Name | % of Total AUM |
% of Derivatives |
% of Net AUM |
| Equity & Equity Related | |||
| Banks | 23.71% | ||
| ● ICICI Bank Ltd. | 7.59% | ||
| ● HDFC Bank Ltd. | 6.15% | ||
| ● Axis Bank Ltd. | 3.57% | ||
| ● State Bank of India | 3.40% | ||
| ● Federal Bank Ltd. | 3.00% | ||
| Finance | 9.13% | ||
| TVS Holdings Ltd. | 2.21% | ||
| Bajaj Finance Ltd. | 2.00% | ||
| Cholamandalam Investment and Finance Company Ltd. | 1.70% | ||
| SBFC Finance Ltd. | 1.31% | ||
| L&T Finance Ltd. | 1.10% | ||
| Home First Finance Company India Ltd. | 0.80% | ||
| IT - Software | 7.35% | ||
| ● Infosys Ltd. | 3.92% | ||
| Tech Mahindra Ltd. | 2.59% | ||
| Persistent Systems Ltd. | 0.84% | ||
| Retailing | 5.64% | ||
| ● Eternal Ltd. | 2.90% | ||
| Avenue Supermarts Ltd. | 1.27% | ||
| Meesho Ltd. | 1.17% | ||
| Urban Company Ltd. | 0.31% | ||
| Pharmaceuticals & Biotechnology | 5.23% | ||
| Emcure Pharmaceuticals Ltd. | 1.80% | ||
| Sun Pharmaceutical Industries Ltd. | 0.99% | ||
| CORONA Remedies Ltd. | 0.66% | ||
| Sai Life Sciences Ltd. | 0.62% | ||
| Mankind Pharma Ltd. | 0.53% | ||
| Ajanta Pharmaceuticals Ltd. | 0.45% | ||
| Biocon Ltd. | 0.17% | ||
| Petroleum Products | 3.80% | ||
| ● Reliance Industries Ltd. | 3.80% | ||
| Healthcare Services | 3.53% | ||
| Fortis Healthcare Ltd. | 1.93% | ||
| Thyrocare Technologies Ltd. | 1.32% | ||
| Suraksha Diagnostic Ltd. | 0.28% | ||
| Automobiles | 3.33% | ||
| ● Mahindra & Mahindra Ltd. | 2.93% | ||
| Ather Energy Ltd. | 0.39% | ||
| Consumer Durables | 3.28% | ||
| Titan Company Ltd. | 1.57% | ||
| Dixon Technologies (India) Ltd. | 1.17% | ||
| LG Electronics India Ltd. | 0.35% | ||
| V-Guard Industries Ltd. | 0.19% | ||
| Personal Products | 3.04% | ||
| Godrej Consumer Products Ltd. | 1.81% | ||
| Gillette India Ltd. | 1.23% |
| Sector/Issuer Name | % of Total AUM |
% of Derivatives |
% of Net AUM |
| Telecom - Services | 2.91% | ||
| ● Bharti Airtel Ltd. | 2.91% | ||
| Power | 2.86% | ||
| Adani Power Ltd. | 1.52% | ||
| NTPC Ltd. | 1.34% | ||
| Industrial Products | 2.63% | ||
| Cummins India Ltd. | 2.03% | ||
| Kirloskar Brothers Ltd. | 0.60% | ||
| Insurance | 2.48% | ||
| Max Financial Services Ltd. | 0.96% | ||
| Medi Assist Healthcare Services Ltd. | 0.88% | ||
| Go Digit General Insurance Ltd. | 0.64% | ||
| Capital Markets | 2.36% | ||
| Computer Age Management Services Ltd. | 1.64% | ||
| Nippon Life India Asset Management Ltd. | 0.72% | ||
| Non - Ferrous Metals | 2.21% | ||
| Hindalco Industries Ltd. | 2.21% | ||
| Construction | 1.91% | ||
| Larsen & Toubro Ltd. | 1.91% | ||
| Beverages | 1.82% | ||
| Varun Beverages Ltd. | 1.82% | ||
| Cement & Cement Products | 1.64% | ||
| Ambuja Cements Ltd. | 1.64% | ||
| Realty | 1.60% | ||
| Aditya Birla Real Estate Ltd. | 0.98% | ||
| Prestige Estates Projects Ltd. | 0.62% | ||
| Auto Components | 1.52% | ||
| Bosch Ltd. | 1.52% | ||
| Leisure Services | 1.41% | ||
| Thomas Cook (India) Ltd. | 0.82% | ||
| Chalet Hotels Ltd. | 0.59% | ||
| Transport Infrastructure | 1.16% | ||
| Adani Ports and Special Economic Zone Ltd. | 1.16% | ||
| Fertilizers & Agrochemicals | 1.08% | ||
| Sumitomo Chemical India Ltd. | 1.08% | ||
| Agricultural Food & other Products | 1.00% | ||
| Balrampur Chini Mills Ltd. | 1.00% | ||
| Diversified FMCG | 0.91% | ||
| Hindustan Unilever Ltd. | 0.91% | ||
| Chemicals & Petrochemicals | 0.69% | ||
| Vinati Organics Ltd. | 0.69% | ||
| Miscellaneous | 0.00% | ||
| Net Cash and Cash Equivalent | 1.76% | ||
| Grand Total | 100.00% |
Miscellaneous includes securities with exposure of less than 0.01%
| Product Label | |
| Scheme Name | |
| Aditya Birla Sun Life ELSS Tax Saver Fund An Open ended Equity Linked Saving Scheme with a statutory lock-in of 3 years and tax benefit |
|
| This product is suitable for investors who are seeking*: | |
|
|
Risk-o-meter  |
Benchmark Risk-o-meter Nifty 500 TRI  |
| *Investors should consult their financial advisors if in doubt whether the product is suitable for them. | |